CT Private Equity Trust (CTPE) Competitors GBX 452.58 -1.42 (-0.31%) As of 12:51 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider Trades CTPE vs. WWH, IHP, JFJ, GROW, and BPCRShould you buy CT Private Equity Trust stock or one of its competitors? CT Private Equity Trust's main competitors and comparable companies include Worldwide Healthcare (WWH), IntegraFin (IHP), JPMorgan Japanese (JFJ), Molten Ventures (GROW), and BioPharma Credit (BPCR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry. CTPE vs. WWHCTPE vs. IHPCTPE vs. JFJCTPE vs. GROWCTPE vs. BPCRHow does CT Private Equity Trust compare to Worldwide Healthcare?Worldwide Healthcare (LON:WWH) and CT Private Equity Trust (LON:CTPE) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations and dividends. Is WWH or CTPE more profitable? Worldwide Healthcare has a net margin of 85.46% compared to CT Private Equity Trust's net margin of 73.44%. Worldwide Healthcare's return on equity of 8.01% beat CT Private Equity Trust's return on equity.Company Net Margins Return on Equity Return on Assets Worldwide Healthcare85.46% 8.01% -2.02% CT Private Equity Trust 73.44%7.01%1.91% Which has more risk and volatility, WWH or CTPE? Worldwide Healthcare has a beta of 0.262, meaning that its share price is 74% less volatile than the broader market. Comparatively, CT Private Equity Trust has a beta of 0.902, meaning that its share price is 10% less volatile than the broader market. Is WWH or CTPE a better dividend stock? Worldwide Healthcare pays an annual dividend of GBX 2.40 per share and has a dividend yield of 0.6%. CT Private Equity Trust pays an annual dividend of GBX 28.22 per share and has a dividend yield of 6.3%. Worldwide Healthcare pays out 9.0% of its earnings in the form of a dividend. CT Private Equity Trust pays out 57.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Which has preferable earnings and valuation, WWH or CTPE? Worldwide Healthcare has higher revenue and earnings than CT Private Equity Trust. CT Private Equity Trust is trading at a lower price-to-earnings ratio than Worldwide Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWorldwide Healthcare£118.16M11.06£227.88M£26.7014.31CT Private Equity Trust£36.40M8.83£5.40M£49.049.19 Do institutionals and insiders hold more shares of WWH or CTPE? 7.7% of Worldwide Healthcare shares are held by institutional investors. Comparatively, 16.8% of CT Private Equity Trust shares are held by institutional investors. 0.2% of Worldwide Healthcare shares are held by insiders. Comparatively, 0.4% of CT Private Equity Trust shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts prefer WWH or CTPE? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Worldwide Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00CT Private Equity Trust 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to WWH or CTPE? In the previous week, Worldwide Healthcare had 1 more articles in the media than CT Private Equity Trust. MarketBeat recorded 1 mentions for Worldwide Healthcare and 0 mentions for CT Private Equity Trust. Worldwide Healthcare's average media sentiment score of 0.75 beat CT Private Equity Trust's score of 0.00 indicating that Worldwide Healthcare is being referred to more favorably in the media. Company Overall Sentiment Worldwide Healthcare Positive CT Private Equity Trust Neutral SummaryWorldwide Healthcare beats CT Private Equity Trust on 9 of the 17 factors compared between the two stocks.How does CT Private Equity Trust compare to IntegraFin?CT Private Equity Trust (LON:CTPE) and IntegraFin (LON:IHP) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability. Does the media prefer CTPE or IHP? In the previous week, IntegraFin had 6 more articles in the media than CT Private Equity Trust. MarketBeat recorded 6 mentions for IntegraFin and 0 mentions for CT Private Equity Trust. IntegraFin's average media sentiment score of 0.93 beat CT Private Equity Trust's score of 0.00 indicating that IntegraFin is being referred to more favorably in the news media. Company Overall Sentiment CT Private Equity Trust Neutral IntegraFin Positive Which has stronger valuation & earnings, CTPE or IHP? IntegraFin has higher revenue and earnings than CT Private Equity Trust. CT Private Equity Trust is trading at a lower price-to-earnings ratio than IntegraFin, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCT Private Equity Trust£36.40M8.83£5.40M£49.049.19IntegraFin£165.40M7.48£52.54M£19.1019.59 Do insiders and institutionals hold more shares of CTPE or IHP? 16.8% of CT Private Equity Trust shares are held by institutional investors. Comparatively, 43.7% of IntegraFin shares are held by institutional investors. 0.4% of CT Private Equity Trust shares are held by company insiders. Comparatively, 14.5% of IntegraFin shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Do analysts recommend CTPE or IHP? IntegraFin has a consensus price target of GBX 440, suggesting a potential upside of 17.57%. Given IntegraFin's higher possible upside, analysts clearly believe IntegraFin is more favorable than CT Private Equity Trust.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CT Private Equity Trust 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00IntegraFin 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Is CTPE or IHP a better dividend stock? CT Private Equity Trust pays an annual dividend of GBX 28.22 per share and has a dividend yield of 6.3%. IntegraFin pays an annual dividend of GBX 11.30 per share and has a dividend yield of 3.0%. CT Private Equity Trust pays out 57.5% of its earnings in the form of a dividend. IntegraFin pays out 59.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. CT Private Equity Trust is clearly the better dividend stock, given its higher yield and lower payout ratio. Is CTPE or IHP more profitable? CT Private Equity Trust has a net margin of 73.44% compared to IntegraFin's net margin of 28.60%. IntegraFin's return on equity of 27.60% beat CT Private Equity Trust's return on equity.Company Net Margins Return on Equity Return on Assets CT Private Equity Trust73.44% 7.01% 1.91% IntegraFin 28.60%27.60%20.29% Which has more volatility and risk, CTPE or IHP? CT Private Equity Trust has a beta of 0.902, suggesting that its stock price is 10% less volatile than the broader market. Comparatively, IntegraFin has a beta of 1.276, suggesting that its stock price is 28% more volatile than the broader market. SummaryIntegraFin beats CT Private Equity Trust on 12 of the 18 factors compared between the two stocks.How does CT Private Equity Trust compare to JPMorgan Japanese?JPMorgan Japanese (LON:JFJ) and CT Private Equity Trust (LON:CTPE) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, media sentiment, analyst recommendations, valuation, risk and institutional ownership. Is JFJ or CTPE more profitable? JPMorgan Japanese has a net margin of 96.52% compared to CT Private Equity Trust's net margin of 73.44%. JPMorgan Japanese's return on equity of 20.00% beat CT Private Equity Trust's return on equity.Company Net Margins Return on Equity Return on Assets JPMorgan Japanese96.52% 20.00% 8.06% CT Private Equity Trust 73.44%7.01%1.91% Which has more volatility & risk, JFJ or CTPE? JPMorgan Japanese has a beta of 1.024, suggesting that its share price is 2% more volatile than the broader market. Comparatively, CT Private Equity Trust has a beta of 0.902, suggesting that its share price is 10% less volatile than the broader market. Does the media prefer JFJ or CTPE? In the previous week, JPMorgan Japanese had 2 more articles in the media than CT Private Equity Trust. MarketBeat recorded 2 mentions for JPMorgan Japanese and 0 mentions for CT Private Equity Trust. JPMorgan Japanese's average media sentiment score of 0.74 beat CT Private Equity Trust's score of 0.00 indicating that JPMorgan Japanese is being referred to more favorably in the media. Company Overall Sentiment JPMorgan Japanese Positive CT Private Equity Trust Neutral Do insiders and institutionals have more ownership in JFJ or CTPE? 18.9% of JPMorgan Japanese shares are held by institutional investors. Comparatively, 16.8% of CT Private Equity Trust shares are held by institutional investors. 0.1% of JPMorgan Japanese shares are held by company insiders. Comparatively, 0.4% of CT Private Equity Trust shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has preferable earnings & valuation, JFJ or CTPE? JPMorgan Japanese has higher revenue and earnings than CT Private Equity Trust. JPMorgan Japanese is trading at a lower price-to-earnings ratio than CT Private Equity Trust, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJPMorgan Japanese£245.55M4.83£194.81M£149.065.35CT Private Equity Trust£36.40M8.83£5.40M£49.049.19 Do analysts rate JFJ or CTPE? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score JPMorgan Japanese 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00CT Private Equity Trust 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is JFJ or CTPE a better dividend stock? JPMorgan Japanese pays an annual dividend of GBX 8.70 per share and has a dividend yield of 1.1%. CT Private Equity Trust pays an annual dividend of GBX 28.22 per share and has a dividend yield of 6.3%. JPMorgan Japanese pays out 5.8% of its earnings in the form of a dividend. CT Private Equity Trust pays out 57.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. SummaryJPMorgan Japanese beats CT Private Equity Trust on 11 of the 17 factors compared between the two stocks.How does CT Private Equity Trust compare to Molten Ventures?Molten Ventures (LON:GROW) and CT Private Equity Trust (LON:CTPE) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation. Do insiders & institutionals hold more shares of GROW or CTPE? 40.5% of Molten Ventures shares are held by institutional investors. Comparatively, 16.8% of CT Private Equity Trust shares are held by institutional investors. 1.6% of Molten Ventures shares are held by company insiders. Comparatively, 0.4% of CT Private Equity Trust shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, GROW or CTPE? Molten Ventures has a beta of 1.9564402, meaning that its share price is 96% more volatile than the broader market. Comparatively, CT Private Equity Trust has a beta of 0.902, meaning that its share price is 10% less volatile than the broader market. Is GROW or CTPE more profitable? Molten Ventures has a net margin of 75.09% compared to CT Private Equity Trust's net margin of 73.44%. Molten Ventures' return on equity of 9.21% beat CT Private Equity Trust's return on equity.Company Net Margins Return on Equity Return on Assets Molten Ventures75.09% 9.21% -3.46% CT Private Equity Trust 73.44%7.01%1.91% Does the media favor GROW or CTPE? In the previous week, Molten Ventures had 1 more articles in the media than CT Private Equity Trust. MarketBeat recorded 1 mentions for Molten Ventures and 0 mentions for CT Private Equity Trust. Molten Ventures' average media sentiment score of 0.00 equaled CT Private Equity Trust'saverage media sentiment score. Company Overall Sentiment Molten Ventures Neutral CT Private Equity Trust Neutral Do analysts rate GROW or CTPE? Molten Ventures currently has a consensus price target of GBX 638.67, suggesting a potential downside of 9.23%. Given Molten Ventures' higher probable upside, analysts clearly believe Molten Ventures is more favorable than CT Private Equity Trust.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Molten Ventures 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00CT Private Equity Trust 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation and earnings, GROW or CTPE? CT Private Equity Trust has lower revenue, but higher earnings than Molten Ventures. CT Private Equity Trust is trading at a lower price-to-earnings ratio than Molten Ventures, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMolten Ventures£148M8.16-£33.58M£69.0010.20CT Private Equity Trust£36.40M8.83£5.40M£49.049.19 SummaryMolten Ventures beats CT Private Equity Trust on 11 of the 14 factors compared between the two stocks.How does CT Private Equity Trust compare to BioPharma Credit?CT Private Equity Trust (LON:CTPE) and BioPharma Credit (LON:BPCR) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability, media sentiment and institutional ownership. Is CTPE or BPCR a better dividend stock? CT Private Equity Trust pays an annual dividend of GBX 28.22 per share and has a dividend yield of 6.3%. BioPharma Credit pays an annual dividend of GBX 7 per share and has a dividend yield of 720.2%. CT Private Equity Trust pays out 57.5% of its earnings in the form of a dividend. BioPharma Credit pays out 73.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Is CTPE or BPCR more profitable? BioPharma Credit has a net margin of 89.20% compared to CT Private Equity Trust's net margin of 73.44%. BioPharma Credit's return on equity of 9.39% beat CT Private Equity Trust's return on equity.Company Net Margins Return on Equity Return on Assets CT Private Equity Trust73.44% 7.01% 1.91% BioPharma Credit 89.20%9.39%4.98% Do insiders & institutionals have more ownership in CTPE or BPCR? 16.8% of CT Private Equity Trust shares are owned by institutional investors. Comparatively, 31.3% of BioPharma Credit shares are owned by institutional investors. 0.4% of CT Private Equity Trust shares are owned by company insiders. Comparatively, 0.1% of BioPharma Credit shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media refer more to CTPE or BPCR? In the previous week, CT Private Equity Trust's average media sentiment score of 0.00 equaled BioPharma Credit'saverage media sentiment score. Company Overall Sentiment CT Private Equity Trust Neutral BioPharma Credit Neutral Which has more volatility and risk, CTPE or BPCR? CT Private Equity Trust has a beta of 0.902, indicating that its share price is 10% less volatile than the broader market. Comparatively, BioPharma Credit has a beta of 0.22688746, indicating that its share price is 77% less volatile than the broader market. Do analysts recommend CTPE or BPCR? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CT Private Equity Trust 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00BioPharma Credit 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has higher valuation and earnings, CTPE or BPCR? BioPharma Credit has higher revenue and earnings than CT Private Equity Trust. BioPharma Credit is trading at a lower price-to-earnings ratio than CT Private Equity Trust, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCT Private Equity Trust£36.40M8.83£5.40M£49.049.19BioPharma Credit£110.03M0.10£10.42B£9.540.10 SummaryCT Private Equity Trust beats BioPharma Credit on 8 of the 15 factors compared between the two stocks. Get CT Private Equity Trust News Delivered to You Automatically Sign up to receive the latest news and ratings for CTPE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTPE vs. The Competition ExportMetricCT Private Equity TrustCapital Markets IndustryFinance SectorLON ExchangeMarket Cap£322.79M£5.14B£13.56B£2.79BDividend Yield6.26%7.70%6.12%6.26%P/E Ratio9.2330.3425.16366.22Price / Sales8.871,166.19472.2289,356.74Price / Cash22.6947.4929.6627.81Price / Book0.683.442.716.91Net Income£5.40M£415.07M£1.32B£5.88B7 Day Performance-1.40%-0.49%0.14%-1.14%1 Month Performance-3.42%-3.24%-2.35%-1.92%1 Year Performance-5.71%7.18%10.12%21.34% CT Private Equity Trust Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTPECT Private Equity TrustN/AGBX 452.58-0.3%N/A-5.4%£322.79M£36.40M9.23N/AWWHWorldwide HealthcareN/AGBX 370.50-0.7%N/A+7.2%£1.27B£118.16M13.88N/APositive NewsIHPIntegraFin3.7706 of 5 starsGBX 368-1.2%GBX 440+19.6%-1.9%£1.22B£165.40M19.273,520JFJJPMorgan JapaneseN/AGBX 811+0.1%N/A+9.7%£1.21B£245.55M5.44N/ANews CoverageGROWMolten Ventures0.7999 of 5 starsGBX 651-1.0%GBX 638.67-1.9%+36.4%£1.12B£148M9.4320News CoverageGap Up Related Companies and Tools Related Companies Worldwide Healthcare Alternatives IntegraFin Alternatives JPMorgan Japanese Alternatives Molten Ventures Alternatives BioPharma Credit Alternatives Genesis Emerging Markets Fund Alternatives Edinburgh Investment Alternatives Fidelity China Special Alternatives Baillie Gifford US Growth Alternatives TwentyFour Income Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CTPE) was last updated on 10/26/2026 by MarketBeat.com Staff. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredNNVC Is Heating Up as Its Antiviral Pipeline Advances!NanoViricides (NYSE American: NNVC) is advancing NV-387, a broad-spectrum antiviral candidate, into Phase II t...Equiscreen | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredWhy tech stocks are deadAI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the b...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredBeginner’s Guide to GoldInflation, trade wars, and market volatility have many savers rethinking how they protect retirement funds. A ...Goldco Direct, LLC | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CT Private Equity Trust PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share CT Private Equity Trust With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
